Articles tagged with Covid 19 Vaccines
The study found that supplementing COVID-19 claims records with Immunization Information Systems vaccination data increased vaccinated individual numbers, yet potential under-recording remained. Improving reporting to Immunization Information Systems could enable frequent updates of vaccination status for all individuals and vaccines.
A new study investigates lockdowns and vaccines' complementary or substitutive roles in mitigating COVID-19's effects. The researchers found that vaccinations should be relaxed after substantial vaccination rates, but vastly different policies may be optimal depending on parameters.
Researchers found that people with severe obesity have a higher risk of severe COVID-19 outcomes and may need more frequent booster doses. Immunity declines faster in obese individuals, putting them at greater risk of infection over time.
MIT chemists develop rapid test to determine whether individuals have neutralizing antibodies against Covid-19, offering protection against future infections. The technique uses a fingerprint of sugar molecules to identify neutralizing antibodies in blood samples.
A new University of Ottawa study found that educated Black individuals in Canada were hesitant to receive the COVID-19 vaccine due to distrust in the healthcare network. The survey revealed that health literacy and racial discrimination played a significant role in this mistrust.
A new COVID-19 vaccine developed at Rutgers University may provide more durable protection against SARS-CoV-2 and its emerging variants than existing vaccines. The vaccine, dubbed MT-001, uses a unique section of the spike protein as its immunogen, which could potentially elicit broadly neutralizing antibodies.
Researchers found that Fiocruz's partnership with AstraZeneca was crucial to the success of COVID-19 vaccine production in Brazil. The partnership demonstrated the importance of technology transfer agreements, regulatory support, and political skill. Bio-Manguinhos facility played a significant role in producing vaccines, making over 5...
Researchers identified the immune signature of heart inflammation cases linked to mRNA vaccines, finding it caused by a generalized immune response rather than antibodies created by the vaccine. This knowledge may enable optimizing mRNA vaccines and reducing the risk of myocarditis in vaccinated individuals.
A study from Ann & Robert H Lurie Children's Hospital of Chicago found that the 'trusted parents' and 'safe and tested' message types increased Black parents' intentions to vaccinate their children. Messages emphasizing vaccine safety and efficacy were effective in addressing concerns among hesitant parents.
A study found that declines in racial disparities in COVID-19 mortality rates were largely due to increases in mortality among White individuals, rather than decreases in non-Hispanic Black and Hispanic populations. The shift from urban to rural areas also contributed to the decline.
The study found that COVID-19 vaccine-induced immunity rapidly declines after primary vaccination and booster doses, leading to a decrease in protection against Omicron and Delta infections. The results highlight the need for targeted vaccination strategies to combat the evolving SARS-CoV-2 virus.
A Swedish study of nearly 3 million women found weak and inconsistent associations between COVID-19 vaccination and contact with healthcare for postmenopausal bleeding. However, the researchers suggest that a causal effect is unlikely due to the limitations of self-reporting data.
Researchers from Baidu Research have developed an AI algorithm, LinearDesign, that boosts COVID-19 mRNA vaccine antibody response by 128-fold. The algorithm takes a mere 11 minutes to generate the most stable mRNA sequence encoding Spike protein.
A study found that psychological factors, such as beliefs and attitude towards the COVID-19 vaccine, significantly contribute to the onset and severity of adverse effects. The researchers investigated how fear, trust, and expectations affect side effects and explained 30% of the intensity of symptoms.
Researchers at the University of Missouri identified occludin protein as a mediator for cell-to-cell transmission of coronavirus. The study found that damaged occludin protein enables virus replication and spread to neighboring cells, worsening symptoms.
Researchers have identified mechanisms behind the emergence of new and contagious coronavirus variants by analyzing over three million genome sequences. The study found that concordant substitutions occurring at other sites influence the likelihood of a substitution occurring at a specific site, leading to unexpected variant emergence.
The NVX-CoV2373 vaccine demonstrated strong safety and immunogenicity profiles in a clinical trial of over 2,200 adolescents. The study found the vaccine to be efficacious in preventing COVID-19, including the Delta variant.
A new study by Cedars-Sinai Medical Center finds that people with long COVID-19 produce higher levels of antibodies against the virus than those without. The elevated antibody levels persist for months longer than expected after receiving a COVID-19 vaccine, sparking further research into the condition.
A world-leading international trial has found that the BCG vaccine does not protect healthcare workers against COVID-19, despite boosting 'front-line' immunity in infants and protecting against respiratory infections. The research involved 3988 healthcare workers and showed a higher risk of symptomatic COVID-19 in the BCG group.
Researchers discovered a 'cocktail' of human antibodies that show promise in fighting severe SARS-CoV-2 infections, including Omicron variants. The study revealed how the original Moderna vaccine could prompt the body to produce these broad-spectrum antibodies.
Researchers at MIT have created a vaccine printer that can produce hundreds of vaccine doses in a day, using microneedle patches that can be stored long-term at room temperature. The printer can be deployed anywhere vaccines are needed, providing on-demand vaccine production.
A Brazilian study analyzed data from over 40,000 patients admitted to ICUs and found lower mortality rates during the Omicron outbreak compared to previous strains of Covid-19. Vaccination coverage contributed to the lower mortality observed in the Omicron period, but vulnerable patients remain at risk.
A large-scale registry study in Finland identified factors associated with COVID-19 vaccination uptake, including low labor income and mental health issues. The study found that individuals in vulnerable positions were the least likely to vaccinate, highlighting the need for targeted vaccination campaigns.
A recent study found that 45% of parents believe the vaccine's long-term risks outweigh the benefits, while 18% fear being held responsible if their child gets sick after vaccination. To boost child vaccination rates, experts suggest addressing parental perceptions and increasing transparency.
A study of 55,000 Canadian patients with COVID-19 found that vaccination significantly reduced severe outcomes and burden on healthcare systems. The research also highlights the importance of vaccination in reducing mortality rates associated with COVID-19.
A study published in Communications Biology suggests that gut bacteria's digestion of fucose sugar may be behind weaker immune responses to the COVID-19 mRNA vaccine. Individuals with lower T-cell responses had higher expression of genes FOS and ATF3, which are part of a larger group controlling T-cell survival and activity.
Focusing public health messages on protecting oneself versus others has a significant impact on vaccination rates. A study found that messages emphasizing protection of one's community led to higher odds of COVID-19 vaccination than those focused on personal protection.
Researchers found that removing ovaries during a benign hysterectomy increases the risk of hospitalization for cardiovascular disease in premenopausal women, but not necessarily for cancer. The study supports current recommendations to conserve ovaries in premenopausal patients at low risk for ovarian cancer.
New research shows that COVID-19 vaccines have directly saved at least 1,004,927 lives across Europe between December 2020 and March 2023. The majority of these lives were saved in people aged 60 years and older, with the first booster accounting for almost two-thirds of lives saved.
Researchers recognize the need for improved COVID-19 vaccines to prevent transmission and infection. Mucosal vaccines targeting the respiratory tract could be effective in blocking SARS-CoV-2 transmission and reducing disease burden.
A large study of over 3 million patients receiving the mRNA COVID-19 vaccine found extremely rare cases of retinal vascular occlusion. The researchers concluded that there is no evidence suggesting an association between the vaccine and newly diagnosed RVO, rates similar to those of other vaccinations.
A global study of 9,555 individuals found a 4% increase in heavy bleeding days and total bleeding quantity after COVID-19 vaccination. Changes often resolve by the first post-vaccination menstrual cycle.
A multi-state study confirms the Pfizer-BioNTech mRNA COVID-19 vaccine's effectiveness in children and adolescents against moderate and severe COVID-19 outcomes. The study found that vaccination provided significant protection, but effectiveness decreased during Omicron dominance, with a booster dose increasing protection.
The primary COVID-19 vaccines provided adequate protection against transmission, hospitalization, and death, but their effectiveness waned in the face of the Omicron variant. The study found that vaccines developed prior to Omicron's emergence were 83% effective against infection at baseline, but this decreased to 47% by 40 weeks.
Researchers found bivalent boosters to be 67% effective in preventing hospitalization and death, with effectiveness waning after four weeks. The boosters also reduced the risk of infection and death against newer omicron strains.
A new study found that the Pfizer bivalent COVID-19 booster vaccine reduced hospitalization and death risks by 72% and 68%, respectively, in adults aged 65 years and older. The study highlights the importance of bivalent booster vaccination in high-risk populations.
A new AI-generated vaccine targeting T-cells provides broad coverage against future COVID-19 variants, potentially lasting longer than current antibody-based vaccines. This innovation has the potential to be used for seasonal flu and other vaccines, offering a long-lasting solution to emerging viral diseases.
A new UCLA-led study found that individuals with traditional cultural values tend to take stricter COVID-19 precautions globally, with 21 of 27 countries showing a strong link between the two. In contrast, factors like distrust of science and concerns about the economy in the US suppressed cautionary behavior among social conservatives.
A Rutgers study finds that individuals who avoid COVID-19 precautions are more likely to buy firearms, especially those with liberal or moderate political views. These groups also tend to trust less scientific information and have concerns about physical attacks, leading them to prioritize firearm ownership as a means of self-protection.
A new study found that a handful of key Twitter influencers effectively countered vaccine misinformation and promoted accurate information about vaccines. Social media influencers can use their social capital to challenge the spread of conspiracy theories.
A national survey found that South Carolina residents were more hesitant to receive COVID-19 vaccines due to low confidence in public health scientists and collective responsibility. Researchers hope that targeted education efforts will address these factors and reduce vaccine hesitancy.
Researchers at Weill Cornell Medicine have identified an antibody that blocks infection by all dominant COVID-19 variants, including Omicron. The discovery could lead to new antibody-based treatments and more effective vaccines.
A study led by ISGlobal found that exposure to air pollution before the pandemic was associated with lower antibody responses to COVID-19 vaccines, particularly in uninfected individuals. The study measured IgM, IgG, and IgA antibodies in participants exposed to fine particulate matter, nitrogen dioxide, and black carbon.
Researchers at the University of Chicago have found that adding small molecules called immunomodulators to vaccine adjuvants can regulate the body's response to vaccines, reducing negative side effects. The study increased antibody response in flu vaccine models and reduced inflammation in typhoid vaccine models.
A UCLA study found that individuals who support the Black Lives Matter movement tend to be less hesitant about receiving COVID-19 vaccines. The researchers suggest that altruistic feelings about interactions between different social groups may account for this phenomenon.
A recent US study found that people living with HIV performed worse on cognitive tests after SARS-CoV-2 infection compared to those without HIV, but these differences were attributable to HIV rather than COVID-19. However, vaccinated individuals experienced declines in processing speed following COVID-19.
New research from Washington University School of Medicine reveals that updated booster shots targeting specific COVID-19 variants can elicit a broad antibody response capable of neutralizing new variants. Periodic boosters may be necessary to maintain population immunity as the virus continues to evolve.
Researchers found that lipid nanoparticles stimulate innate immune cells more efficiently in younger individuals, but less so in older adults. The study suggests that understanding the immune response to LNPs can help develop strategies to improve vaccine responses in the aged population.
A new live attenuated SARS-CoV-2 vaccine administered through the nose has shown better immunity than injected vaccines in hamster models, reducing transmissibility. The vaccine stimulates local immunity by activating antibody immunoglobulin A and memory T cells, providing early protection against COVID-19.
A WPI-led team used computational modeling to create a detailed picture of the SARS-COV-2 virus envelope, revealing its elliptical shape and changing structure. This discovery could lead to more effective therapies and vaccines, as well as a better understanding of the virus's properties.
Research found increased trust in scientists during COVID-19 pandemic, with polarized attitudes emerging, influencing behavior and vaccine adoption. Those with initial positive views became even more positive, while those with negative views became more entrenched.
A new analysis shows that the US has substantially higher death rates at all but the oldest ages compared to five high-income European countries. The excess death gap widened during the Covid-19 pandemic, with the number of excess deaths nearly doubling between 2019 and 2021.
Research finds COVID-19 vaccine fatigue is driven by confidence in institutions and communication campaigns, with positive incentives boosting willingness among partially vaccinated groups. Effective strategies include adapted vaccines, low-barrier access, and expert consensus.
A small molecule discovered by University of Houston researchers could potentially shorten the course of SARS-CoV-2 infection, offering a new alternative treatment option for COVID-19. The compound, CD04872SC, has shown promise in neutralizing the virus and its variants Delta and Omicron.
Researchers found that COVID-19 vaccination generates robust T cell responses in haematology patients, on par with healthy individuals. The study provides key insights for future immunisation strategies and shows that mRNA vaccines can elicit strong T cell immunity in patients with co-morbidities.
A study found that socially vulnerable populations have poorer COVID-19 outcomes despite similar vaccine effectiveness, due to lower vaccination rates. The VISION Network analyzed electronic health record data and immunization records to highlight the need for targeted public health efforts on vaccine coverage.
A study of 1,678 participants found that low benefit expectations, negative experiences, and catastrophizing are associated with COVID-19 vaccination adverse effects. Clinician-patient interactions and public vaccine campaigns may be optimized by contextualizing information about vaccines.
Researchers examine how chronological and biological age impact vaccine effectiveness, finding that both factors influence immune system capacity to mount responses. The study highlights the need for further research into 'immune aging' risk and departures from healthy aging.
A recent study published in iScience has found that Covid-19 vaccination does not cause concerning changes to periods. Women who have been infected with the Covid-19 virus are at increased risk of menstrual changes such as missed or heavier periods.
The study found that vaccination significantly reduces the risk of long COVID, while factors such as being overweight, female, smoker, or over 40 increase the likelihood of developing the condition. Vaccination halves people's risk of developing long Covid